The fluorescent-labeled phospholipid, 1-palmitoyl-2-[12-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]dodecan oyl] phosphatidylcholine (P-C12-NBD-PC), is highly self-quenched when contained as a high mole percent in phospholipid vesicles. The addition of nonspecific lipid transfer protein (nsLTP), which is identical to sterol carrier protein2, to P-C12-NBD-PC self-quenching vesicles results in a large increase in the fluorescence yield. Evidence is presented that demonstrates that this fluorescence increase results from the binding of P-C12-NBD-PC to one or more low dielectric sites on the nsLTP molecule and that the P-C12-NBD-PC.nsLTP complex can exist free in aqueous solution. The binding is inhibited in the presence of mersalyl, a thiol reagent, and can be reversed with excess cysteine. Transfer of the nsLTP-bound P-C12-NBD-PC to phospholipid vesicles is also demonstrated. The half-times for loading and unloading the P-C12-NBD-PC.nsLTP complex are both 3 orders of magnitude faster than the spontaneous P-C12-NBD-PC transfer between vesicles. These data demonstrate that nsLTP has the necessary properties to bind and carry lipids between membranes.
No takes yet. Share an insight, caveat, or question.
James L. Nichols (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: